WHO classification-based Prognostic Scoring System (WPSS) of primary myelodysplastic syndromes.52
| Variable . | 0 . | 1 . | 2 . | 3 . |
|---|---|---|---|---|
| * Good: normal, -Y, del(5q), del(20q); Poor: complex, chromosome 7 anomalies; Intermediate: other abnormalities | ||||
| ** Transfusion dependency: at least one transfusion every 8 weeks over a period of 4 months | ||||
| Risk groups: very low (score 0), low (score 1), intermediate (score 2), high (score 3–4), very high (score 5–6). | ||||
| WHO Category | RA, RARS, 5q- | RCMD, RCMD-RS | RAEB-1 | RAEB-2 |
| Karyotype* | Good | Intermediate | Poor | — |
| Transfusion requirement** | No | Regular | — | — |
| Variable . | 0 . | 1 . | 2 . | 3 . |
|---|---|---|---|---|
| * Good: normal, -Y, del(5q), del(20q); Poor: complex, chromosome 7 anomalies; Intermediate: other abnormalities | ||||
| ** Transfusion dependency: at least one transfusion every 8 weeks over a period of 4 months | ||||
| Risk groups: very low (score 0), low (score 1), intermediate (score 2), high (score 3–4), very high (score 5–6). | ||||
| WHO Category | RA, RARS, 5q- | RCMD, RCMD-RS | RAEB-1 | RAEB-2 |
| Karyotype* | Good | Intermediate | Poor | — |
| Transfusion requirement** | No | Regular | — | — |